Obesity-related metabolic disorders, such as insulin resistance and lipid metabolism dysregulation, may further exacerbate lung inflammation through complex biological signaling pathways, contributing to the development of emphysema [27]. The gene discussed is INS; the disease is pulmonary emphysema.